Clinical Trial

Target Engagement of Terazosin in Healthy Adults

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of the study is to assess the target engagement of Terazosin (TZ) in a single cohort of 6 healthy adult participants. During the study participants will undergo PET/CT scans, 7-Tesla MRI scans, blood draws, and an optional lumbar puncture (LP.)
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2020-09-15; most recent amendment 2025-01-10.
Status change: Recruiting → Active, Not Recruiting 2023-12-05
Status change: Not Yet Recruiting → Recruiting 2021-03-29
Trial Details
NCT Number NCT04551040
Lead Sponsor University of Iowa
Collaborators: Michael J. Fox Foundation for Parkinson's Research
Conditions Healthy
Enrollment 18 participants
Start Date 2021-03-26
Primary Completion 2023-03-01 (estimated)
Study Completion 2025-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-01-14